1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 5:Secondary complications during follow-up
No. Territorial Ischemia during FU SAH during FU Complete Aneurysmal Thrombotic Occlusion Stent Occlusion during FU 1 No No No No 2 No No No No 3 Yes, brain stem No No Stent occlusion (day 9) → successful recanalization 4 Yes, brain stem/cerebellum, thalamus/pontomedullary No No Stent occlusion (day 32) → successful recanalization 5 Yes, brain stem/cerebellum No No No 6 No No Yes No Ratio 3/6 0/6 1/6 2/6
Note:—FU indicates follow-up.